✦ LIBER ✦

A randomized controlled trial of recombinant interferon α-2b in the treatment of Chinese patients with acute post-transfusion hepatitis C

✍ Scribed by Shinn-Jang Hwang; Shou-Dong Lee; Cho-Yu Chan; Rei-Hwa Lu; Kwang-Juei Lo

Book ID: 118567225
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 538 KB
Volume: 21
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(94)80246-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A multicenter randomized controlled tria

A multicenter randomized controlled trial of recombinant interferon-α2b in patients with acute transfusion-associated hepatitis C

✍ Pietro Lampertico; Mariagrazia Rumi; Raffaella Romeo; Antonio Craxi; Roberta Sof 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 462 KB 👁 1 views

A randomized controlled clinical trial o

A randomized controlled clinical trial of recombinant interferon α-2b in the treatment of acute post-transfusion hepatitis C: A preliminary report

✍ S-J. HWANG; S-D. LEE; Y-H. W. LEE; J-C. WU; C-Y. CHAN; Y-S. HUANG; Y-J. WANG; K- 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 620 KB

Treatment of chronic hepatitis C with re

Treatment of chronic hepatitis C with recombinant human interferon-α2a: Results of a randomized controlled clinical trial

✍ Giulio Diodati; Paola Bonetti; Franco Noventa; Carla Casarin; Massimo Rugge; Ser 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 506 KB

Sixty consecutive patients with chronic hepatitis C were included in a randomized controlled trial of recombinant human interferon-%, vs. no treatment. Treated patients received tapering doses of interferon thrice weekly for 1 yr. Twenty treated cases (66.7%) normalized serum aminotransferase levels

A randomized, double-blind, controlled t

A randomized, double-blind, controlled trial of consensus interferon in the treatment of chinese patients with chronic hepatitis C

✍ Shinn-Jang Hwang; Shou-Dong Lee; Cho-Yu Chan; Rei-Hwa Lu; Full-Young Chang 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 56 KB

A randomised controlled trial of recombi

A randomised controlled trial of recombinant interferon-γ in chinese patients with chronic hepatitis B virus infection

✍ Johnson Y. N. Lau; Dr. C. L. Lai; P. C. Wu; H. T. Chung; Anna S. F. Lok; H. J. L 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 433 KB

## Abstract Nineteen Chinese patients with chronic hepatitis B virus (HBV) infection, seropositive for HBV e antigen (HBeAg) and HBV DNA on at least three occasions in 6 months, were randomised to receive either recombinant human interferongamma (rlFNγ) 0.1 mg/m^2^ intramuscularly thrice weekly for

A randomized controlled trial of lymphob

A randomized controlled trial of lymphoblastoid interferon-α in patients with chronic hepatitis B lacking HBeAg

✍ Giovanna Fattovich; Patrizia Farci; Massimo Rugge; Lucio Brollo; Antonella Manda 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 641 KB

Ongoing hepatitis B virus replication in the presence of antibody to HBeAg can be observed in patients with active liver disease. These forms of chronic hepatitis B have been described as having a poor prognosis. We have conducted a randomized controlled trial to assess the efficacy of lymphoblastoi